Search research articles
Contact Us
Filters
Showing results (21-30 of 39) with videos related to
Page
of 4
Sort By:
Clinical Genetics
|
January 11, 2011
Clinical phenotype variability in patients with hereditary spastic paraplegia type 5 associated with CYP7B1 mutations
A Arnoldi, C Crimella, E Tenderini, et al.
Human Mutation
|
May 18, 2006
Hepatic and neuromuscular forms of glycogenosis type III: nine mutations in AGL
S Lucchiari, S Pagliarani, S Salani, et al.
Neurology
|
December 17, 2008
Management and treatment of glycogenosis type II
B Bembi, E Cerini, C Danesino, et al.
Neurology
|
December 17, 2008
Diagnosis of glycogenosis type II
B Bembi, E Cerini, C Danesino, et al.
Archives of Neurology
|
February 19, 2000
A novel missense mutation (W797R) in the myophosphorylase gene in Spanish patients with McArdle disease
R Fernández, C Navarro, A L Andreu, et al.
Neurology
|
June 27, 2001
Surprises of genetic engineering: a possible model of polyglucosan body disease
N Raben, M Danon, N Lu, et al.
Cell Biochemistry and Function
|
August 26, 2016
MicroRNA signatures predict dysregulated vitamin D receptor and calcium pathways status in limb girdle muscle dystrophies (LGMD) 2A/2B
M Aguennouz, C Lo Giudice, N Licata, et al.
Neurology
|
April 11, 2001
Familial cerebellar ataxia with muscle coenzyme Q10 deficiency
O Musumeci, A Naini, A E Slonim, et al.
Journal of Medical Genetics
|
February 7, 2009
Point mutations and a large intragenic deletion in SPG11 in complicated spastic paraplegia without thin corpus callosum
C Crimella, A Arnoldi, F Crippa, et al.
European Journal of Neurology
|
April 9, 2010
Italian validation of INQoL, a quality of life questionnaire for adults with muscle diseases
V A Sansone, M Panzeri, M Montanari, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 39) with videos related to
Sort By:
Page
of 4
Clinical Genetics
|
January 11, 2011
Clinical phenotype variability in patients with hereditary spastic paraplegia type 5 associated with CYP7B1 mutations
A Arnoldi, C Crimella, E Tenderini, et al.
Human Mutation
|
May 18, 2006
Hepatic and neuromuscular forms of glycogenosis type III: nine mutations in AGL
S Lucchiari, S Pagliarani, S Salani, et al.
Neurology
|
December 17, 2008
Management and treatment of glycogenosis type II
B Bembi, E Cerini, C Danesino, et al.
Neurology
|
December 17, 2008
Diagnosis of glycogenosis type II
B Bembi, E Cerini, C Danesino, et al.
Archives of Neurology
|
February 19, 2000
A novel missense mutation (W797R) in the myophosphorylase gene in Spanish patients with McArdle disease
R Fernández, C Navarro, A L Andreu, et al.
Neurology
|
June 27, 2001
Surprises of genetic engineering: a possible model of polyglucosan body disease
N Raben, M Danon, N Lu, et al.
Cell Biochemistry and Function
|
August 26, 2016
MicroRNA signatures predict dysregulated vitamin D receptor and calcium pathways status in limb girdle muscle dystrophies (LGMD) 2A/2B
M Aguennouz, C Lo Giudice, N Licata, et al.
Neurology
|
April 11, 2001
Familial cerebellar ataxia with muscle coenzyme Q10 deficiency
O Musumeci, A Naini, A E Slonim, et al.
Journal of Medical Genetics
|
February 7, 2009
Point mutations and a large intragenic deletion in SPG11 in complicated spastic paraplegia without thin corpus callosum
C Crimella, A Arnoldi, F Crippa, et al.
European Journal of Neurology
|
April 9, 2010
Italian validation of INQoL, a quality of life questionnaire for adults with muscle diseases
V A Sansone, M Panzeri, M Montanari, et al.
Page
of 4